Why the study?
Does a modified micro solid-phase radioimmunoassay accurately detect acute-phase IgM anti-hepatitis A virus to diagnose viral hepatitis A?
Does a modified micro solid-phase radioimmunoassay accurately detect acute-phase IgM anti-hepatitis A virus to diagnose viral hepatitis A?
A modified radioimmunoassay can effectively detect acute-phase IgM anti-HAV using less than 1 microliter of serum, enabling rapid serodiagnosis of acute viral hepatitis A.
Answers are grounded in this paper and cite their sources.
Promising for minimal-sample acute hepatitis A diagnosis; leaves open human validation from animal data.
A modified micro solid-phase radioimmunoassay (RIA) for antibody to hepatitis A virus (anti-HAV) was developed. This double antibody procedure was performed by coating the surface of a polyvinyl microtiter plate "well" with 200 microliter of a 1:1,000 dilution of a patient's test serum. Purified HAV and 125I-labeled immunoglobulin G (IgG) anti-HAV were then sequentially added to form an antibody sandwich. The specificity and sensitivity of the RIA procedure for anti-HAV were verified by examination of coded human and chimpanzee serum specimens. Radioimmunoassay of early-acute-phase serum specimens from human cases of hepatitis A revealed the presence of anti-HAV activity. Differential examination by RIA of IgG and IgM fractions of acute-phase sera from experimentally infected chimpanzees demonstrated that IgM contained the bulk of the anti-HAV activity. A modification of the RIA procedure for anti-HAV (RIA-IgM blocking), incorporating an incubation step with anti-IgM (Mu chain specific), was further shown to differentiate acute- from convalescent-phase hepatitis A sera. This adapted RIA-IgM blocking procedure required less than 1 microliter of a single acute-phase serum specimen for the diagnosis of viral hepatitis A.
No takes yet. Share an insight, caveat, or question.
Bradley et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: